Eagle Capital Management, LLC
- SEC CIK
- 0001600746
- Latest filing
- Jul 13, 2026
The latest 13F from Eagle Capital Management, LLC covers Q2 2026 (filed Jul 13, 2026): 50 long positions worth $292.9M. The top 10 holdings make up 64.2% of the portfolio, and the largest is Schwab US Dividend Equity ETF at 10.1%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 1
- Est. +$2.30M
- Added
- 14
- Est. +$684.4K
- Reduced
- 20
- Est. −$3.67M
- Sold out
- 0
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
- ETNEaton Corp plc
- Schwab US Dividend Equity ETF808524797+$164.2KAdded
- Schwab U.S. Large-Cap Growth ETF808524300+$156.2KAdded
- Invesco Exch Traded FD Tr II46138E339+$74.6KAdded
- Schwab U.S. Large-Cap ETF808524201+$55.6KAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- Invesco Exch Traded FD Tr II46138E339+0.85 pp3.3% → 4.2%
- ETNEaton Corp plc
- Vanguard Index FDS922908652+0.09 pp2.2% → 2.3%
- Schwab U.S. Large-Cap Growth ETF808524300+0.06 pp1.8% → 1.8%
- Vanguard Industrials ETF92204A603+0.01 pp0.4% → 0.4%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $292.9M
- +$39.2M (+15.5%) vs. prior quarter
- Positions
- 50
- +1 vs. prior quarter
- Top 10 concentration
- 64.2%
- Top 10 as share of value
- Turnover
- 1.1%
- Q2 2026, one quarter
- Average holding period
- 17.0 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $381.8M (Q4 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 13, 2026 | 50 | $292.9M | Schwab US Dividend Equity ETFSPYInvesco QQQ Trust Series I | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 20, 2026 | 49 | $253.7M | Schwab US Dividend Equity ETFSPYInvesco QQQ Trust Series I | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 12, 2026 | 49 | $275.0M | SPYSchwab US Dividend Equity ETFInvesco QQQ Trust Series I | vs. Q3 2025 | SEC |
| Q3 2025 | Oct 16, 2025 | 49 | $264.6M | SPYSchwab US Dividend Equity ETFInvesco QQQ Trust Series I | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 18, 2025 | 44 | $227.5M | SPYSchwab US Dividend Equity ETFAVGO | vs. Q1 2025 | SEC |
| Q1 2025 | Apr 15, 2025 | 40 | $225.9M | Invesco QQQ Trust Series ISchwab US Dividend Equity ETFSPY | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 17, 2025 | 40 | $247.9M | Invesco QQQ Trust Series ISPYSchwab US Dividend Equity ETF | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 18, 2024 | 39 | $240.0M | Invesco QQQ Trust Series ISPYSchwab US Dividend Equity ETF | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 16, 2024 | 39 | $226.9M | Invesco QQQ Trust Series ISPYSchwab US Dividend Equity ETF | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 18, 2024 | 40 | $222.2M | Invesco QQQ Trust Series ISPYSchwab US Dividend Equity ETF | vs. Q4 2023 | SEC |
| Q4 2023 | Jan 26, 2024 | 34 | $205.2M | Invesco QQQ Trust Series ISPYSchwab US Dividend Equity ETF | vs. Q3 2023 | SEC |
| Q3 2023 | Oct 19, 2023 | 33 | $181.7M | Invesco QQQ Trust Series ISPYSchwab US Dividend Equity ETF | vs. Q2 2023 | SEC |
| Q2 2023 | Jul 25, 2023 | 33 | $178.9M | SPYSchwab US Dividend Equity ETFInvesco QQQ Trust Series I | vs. Q1 2023 | SEC |
| Q1 2023 | Apr 13, 2023 | 32 | $153.1M | Schwab US Dividend Equity ETFSPYFidelity MSCI Health Care Index ETF | vs. Q4 2022 | SEC |
| Q4 2022 | Jan 12, 2023 | 34 | $136.3M | Fidelity MSCI Health Care Index ETFDIASPY | vs. Q3 2022 | SEC |
| Q3 2022 | Oct 11, 2022 | 38 | $160.1M | iShares TrFidelity MSCI Health Care Index ETFSPY | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 2, 2022 | 39 | $168.2M | iShares TrFidelity MSCI Health Care Index ETFSPY | vs. Q1 2022 | SEC |
| Q1 2022 | Apr 18, 2022 | 42 | $268.5M | SPDR Series TrustiShares TrSchwab U.S. Broad Market ETF | vs. Q4 2021 | SEC |
| Q4 2021 | Jan 12, 2022 | 49 | $381.8M | SPYSPDR Series TrustInvesco Exch TRD SLF Idx FD | vs. Q3 2021 | SEC |
| Q3 2021 | Dec 2, 2021 | 51 | $368.1M | SPYSPDR Series TrustInvesco Exch TRD SLF Idx FD | vs. Q2 2021 | SEC |
| Q2 2021 | Jul 21, 2021 | 50 | $353.5M | SPYSPDR Series TrustInvesco Exch TRD SLF Idx FD | vs. Q1 2021 | SEC |
| Q1 2021 | Apr 23, 2021 | 48 | $327.3M | SPDR Series TrustSPYInvesco QQQ Trust Series I | – | SEC |